首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Rambam maimonides medical journal

缩写:

ISSN:2076-9172

e-ISSN:2076-9172

IF/分区:1.3/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引525
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
John D Loike,Rabbi Tzvi Flaum,Alan Kadish John D Loike
This paper presents a halakhic-ethical analysis of a 2025 case involving A.S., a brain-dead pregnant woman who was maintained on somatic support to enable fetal maturation and delivery. The case raises profound questions at the intersection...
Yehuda Zadik Yehuda Zadik
The Talmud describes several illnesses attributed to Rabbi Judah ha-Nasi, one of the foremost leaders of the Jewish people after the destruction of the Second Temple, and the compiler of the canonical Mishnah. Among these conditions, Tzafed...
Krishna Nikhila Bonga,Milan Padhan Krishna Nikhila Bonga
Obesity is a complex, multifactorial disease that contributes to a broad range of cardiometabolic, reproductive, and psychological disorders. Representing a major global health challenge, obesity can be addressed by lifestyle modifications ...
Federica Fimiano,Lorenzo Dioscoridi,Marta Stegagnini et al. Federica Fimiano et al.
Background: Ampullary neuroendocrine tumors (NETs) are extremely rare, representing 0.3%-1% of gastrointestinal NETs and less than 2% of periampullary cancers. Due to their rarity, there is limited data on their natural h...
Randy Adiwinata,Caroline Tanadi,Fegita Beatrix Pajala et al. Randy Adiwinata et al.
Immunotherapy using immune checkpoint inhibitor (ICI) has been increasingly used in the oncology treatment field. Although ICIs could help suppress cancer and improve survival rates, it could also lead to certain adverse events, including i...
Nicola Fazaa,Etan Eigner,Ameer Nsair et al. Nicola Fazaa et al.
The evolving landscape of metastatic prostate cancer (mPCa) necessitates a redefinition of the urologist's role, extending beyond diagnosis to active participation in therapeutic and surgical management. This review outlines evidence-based ...